Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly G Paulson

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Cancer Medicine|June 1, 2023
Incidence, demographics, and survival of malignant hemangioendothelioma in the United StatesKelly G Paulson, Vinod Ravi, Brian P Rubin, et al.
The Oncologist|June 24, 2025
Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcomaVinayak Venkataraman, Hannah R Abrams, David S Shulman, et al.
Journal for Immunotherapy of Cancer|December 10, 2020
Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumabJoshua R Veatch, Naina Singhi, Brenda Jesernig, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 13, 2011
Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomasSherry Lee, Kelly G Paulson, Elizabeth P Murchison, et al.
Journal of the American Academy of Dermatology|July 25, 2020
Clinical benefit of baseline imaging in Merkel cell carcinoma: Analysis of 584 patientsNeha Singh, Nora A Alexander, Kristina Lachance, et al.
The Journal of Investigative Dermatology|November 30, 2012
Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stageKelly G Paulson, Jayasri G Iyer, Astrid Blom, et al.
American Journal of Clinical Pathology|November 15, 2013
p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utilityGalina Y Stetsenko, Jacqueline Malekirad, Kelly G Paulson, et al.
The Lancet. Oncology|September 11, 2025
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b studyKelly G Paulson, Sally C M Lau, Myung-Ju Ahn, et al.
Journal of the American Academy of Dermatology|November 6, 2017
Merkel cell carcinoma: Current US incidence and projected increases based on changing demographicsKelly G Paulson, Song Youn Park, Natalie A Vandeven, et al.
American Journal of Clinical Pathology|September 21, 2014
CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based studyKelly G Paulson, Jayasri G Iyer, William T Simonson, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cancer Medicine|June 1, 2023
Incidence, demographics, and survival of malignant hemangioendothelioma in the United StatesKelly G Paulson, Vinod Ravi, Brian P Rubin, et al.
The Oncologist|June 24, 2025
Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcomaVinayak Venkataraman, Hannah R Abrams, David S Shulman, et al.
Journal for Immunotherapy of Cancer|December 10, 2020
Mobilization of pre-existing polyclonal T cells specific to neoantigens but not self-antigens during treatment of a patient with melanoma with bempegaldesleukin and nivolumabJoshua R Veatch, Naina Singhi, Brenda Jesernig, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 13, 2011
Identification and validation of a novel mature microRNA encoded by the Merkel cell polyomavirus in human Merkel cell carcinomasSherry Lee, Kelly G Paulson, Elizabeth P Murchison, et al.
Journal of the American Academy of Dermatology|July 25, 2020
Clinical benefit of baseline imaging in Merkel cell carcinoma: Analysis of 584 patientsNeha Singh, Nora A Alexander, Kristina Lachance, et al.
The Journal of Investigative Dermatology|November 30, 2012
Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stageKelly G Paulson, Jayasri G Iyer, Astrid Blom, et al.
American Journal of Clinical Pathology|November 15, 2013
p63 expression in Merkel cell carcinoma predicts poorer survival yet may have limited clinical utilityGalina Y Stetsenko, Jacqueline Malekirad, Kelly G Paulson, et al.
The Lancet. Oncology|September 11, 2025
Safety and activity of tarlatamab in combination with a PD-L1 inhibitor as first-line maintenance therapy after chemo-immunotherapy in patients with extensive-stage small-cell lung cancer (DeLLphi-303): a multicentre, non-randomised, phase 1b studyKelly G Paulson, Sally C M Lau, Myung-Ju Ahn, et al.
Journal of the American Academy of Dermatology|November 6, 2017
Merkel cell carcinoma: Current US incidence and projected increases based on changing demographicsKelly G Paulson, Song Youn Park, Natalie A Vandeven, et al.
American Journal of Clinical Pathology|September 21, 2014
CD8+ lymphocyte intratumoral infiltration as a stage-independent predictor of Merkel cell carcinoma survival: a population-based studyKelly G Paulson, Jayasri G Iyer, William T Simonson, et al.
Pageof 5